Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05936827Completed

Gyrocardiography- A New Non-invasive Cardiac Measurement Method to Measure Exercise Capacity and Cardiorespiratory Fitness

Role: lead

NCT04290091Completed

Detection of Coronary Artery Disease With Micro Electro-Mechanical Sensors

Role: lead

NCT04444583Completed

Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS) FI

Role: lead

NCT06944405Not ApplicableNot Yet Recruiting

Implementation for Heart Failure Therapies Post-discharge Followed by CardiOSIgnal at HOME

Role: lead

NCT05351775Not ApplicableCompleted

Low Workload Concept for the Detection of Silent Atrial Fibrillation (AF) and Atrial Fibrillation Burden in Patients At High Risk of AF and Stroke

Role: collaborator

NCT04378179Completed

Recognition of Heart Failure With Micro Electro-Mechanical Sensors (REFLECS)

Role: collaborator

All 6 trials loaded